Par Drugs & Chemicals Ltd. NSE: PAR

Par Drugs & Chemicals Ltd. Live Share Price Today, Share Analysis and Chart

Name: Par Drugs & Chemicals Ltd.: Is Infosys Ltd. worth buying?
Item: Par Drugs & Chemicals Ltd.
Rating: 2.554666625
Author: Trendlyne DVM scores

Mid-range Performer

about

Par Drugs & Chemicals is primarily engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets. APIs, also known as “bulk drugs” or “bulk actives” are the principa...

102.96 4.90 (5.00%)

70.45% Fall from 52W High

10,584

NSE Volume

High volume+gain today

NSE 08 Sep, 2025 3:40 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

55.0 / 100

Affordable Valuation

54.3 / 100

Technically Neutral

40.0 / 100

Mid-range Performer These stocks may be affordable or expensive, based on their medium quality and mid-range technical score. However, their reasonable financials are successful in gathering some investor interest. View Similar Embed DVM

No estimates available

Par Drugs & Chemicals Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

VOTE: Is Par Drugs & Chemicals Ltd. worth buying?

36 Votes:

Buy 80.56%

Sell 8.33%

Hold 11.11%

Par Drugs & Chemicals Ltd. Live Share Price Today, Share Analysis and Chart

Par Drugs & Chemicals is primarily engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets. APIs, also known as “bulk drugs” or “bulk actives” are the principa...

70.45% Fall from 52W High

High volume+gain today

SWOT Analysis

Par Drugs & Chemicals Live Price Chart